CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹1,196 Cr | ₹10,145 Cr | ₹884 Cr | ₹884 Cr |
What is the latest Revenue of CORONA REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,196 Cr |
| Mar2025 | ₹10,145 Cr |
| Mar2024 | ₹884 Cr |
| Mar2023 | ₹884 Cr |
How is Revenue of CORONA REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,196 Cr | -88.21 | |
| Mar2025 | ₹10,145 Cr | 1,047.53 | |
| Mar2024 | ₹884 Cr | 0.00 | |
| Mar2023 | ₹884 Cr | - | |
Compare Revenue of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,887.5 Cr | 3.9% | 7.2% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 3.9% |
7.2% |
|
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses